Medtronic wins pain pump case on preemption | Legal News

Medtronic SynchroMed EL pain pump

Medtronic (NYSE:MDT) won another personal injury lawsuit based on the preemption doctrine it helped create in the U.S. Supreme Court’s Riegel v Medtronic decision in 2008.

Preemption holds that patients can’t sue medical device makers in state courts over products that went through the FDA’s most stringent review process, called pre-market approval. But the justices left open a loophole to allow state suits that allege a "parallel claim" that the company in question broke FDA regulations.

In 2000, plaintiff Richard Stengel began using Medtronic’s SynchroMed EL pain pump, an implanted device that delivers medication directly to the spine via an intrathecal catheter. In 2005, Stengel began developing symptoms of paralysis from an inflammation in his spine around the catheter tip. The device and most of the inflammation were removed, "but not in time to prevent the granuloma from rendering Stengel permanently paraplegic," according to court documents.

The FDA approved the first SynchroMed pump in 1998 and later granted approval for the iteration used to treat Stengel. Medtronic recalled that device in 2008.

The U.S. Court of Appeals for the 9th Circuit upheld a lower court’s ruling dismissing Stengel’s case on preemption grounds, but the 3-judge panel’s decision earned a sharp rebuke from a lone dissenter.

"Has Congress or the Supreme Court created such freedom from liability for the manufacturers of such sensitive devices that only in nonexistent cases are the manufacturers subject to suit for damages?" wrote Judge John Noonan, according to court documents. "Are individuals injured by the malfunction of such devices without remedy against the manufacturers of them? That appears to be the conclusion of this court today with its holding that the [Medical Device Act] explicitly preempts and implicitly preempts any state remedy of damages for violation of a state requirement paralleling the MDA."

Judge J. Clifford Wallace, writing for the majority, said the law is clear on the issue of pre-emption.

"We recognize that it may seem harsh to deny compensation to a person who alleges serious injury from a medical device," Wallace wrote. "But such is the direction from the Supreme Court for cases like the one before us. We are required to follow the Court."

Noonan argued that the Stengel’s lawsuit ought to stand because it presents a parallel claim.

"Nothing in the statute prevents provision by a state of ‘a traditional damages remedy’ for violation of ‘state duties’ that parallel the federal requirements," Noonan wrote. "The Stengels have alleged a valid parallel state law cause of action. Arizona law imposes requirements that parallel the requirements under federal law, and Arizona law provides a remedy in damages for the violation of the state requirement."

Medtronic Donna Marquard spokeswoman said the company is pleased that the appeals court’s decision was "consistent with other federal circuit court and Supreme Court rulings that have upheld the doctrine of federal pre-emption for devices which have gone through the rigorous pre-market approval process for medical devices," according to Cronkite News.

"We are disappointed," Stengel lawyer Thomas Cotter told the news site, declining to comment further.

 Bellwether trials near in DePuy ASR lawsuits

The first cases of the roughly 3,500 personal injury lawsuits filed over Johnson & Johnson‘s (NYSE:JNJ) recalled DePuy ASR hip implant are close to going to trial, with lawyers discussing which suits should serve as "bellwether" trials that are representative of the plaintiffs’ claims.

Six plaintiffs in Nevada, Wisconsin, Florida and Utah have successfully petitioned to be excluded from the multi-district litigation. More than 5,000 patients worldwide have sued over the implants, which were recalled in 2010. 
Read more

 BD loses USPTO trademark challenge
Becton Dickinson & Co. (NYSE:BDX) lost its challenge to a ruling from the U.S. Patent and Trademark Office after the U.S. Court of Appeals for the Federal Circuit upheld a USPTO board was right to refuse to register the design of a blood collection tube component as a trademark.
Read more

 Bard loses appeal in row with insurers

A C.R. Bard (NYSE:BCR) insurer won’t have to cover Bard’s costs in a case it lost to Rochester Medical (NSDQ:ROCM) after the U.S. Court of Appeals for the 3rd Circuit upheld a lower court’s ruling for Rochester.
Read more

 Revolutions Medical wins arbitration over RevVac syringe
Revolutions Medical (PINK:RMCP) won an arbitration case against a former consultant, Richard Theriault, after Theriault asserted his Fifth Amendment right against self-incrimination during depositions over Theriault’s claim to the contractual right to produce, manufacture, distribute and sell the RevVac syringe. 
Read more

 Walkwell Int’l sues over yanked reimbursement code
Walkwell International Laboratories Inc. sued Noridian Administrative Services, claiming the insurance claims processor improperly yanked an code for its custom-made ankle support brace.
Read more

RSS From Medical Design & Outsourcing

  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]

Leave a Reply